论文部分内容阅读
作者在既往的研究中已阐明,持续给予长期血液透析病人磷结合剂氢氧化铝后,再给予1αOH
The authors in previous studies have shown that continuous administration of long-term hemodialysis patients phosphorus binding agent aluminum hydroxide, and then given 1α OH